4.6 Article

Low prevalence of cardiac abnormalities in competitive athletes at return-to-play after COVID-19

Journal

JOURNAL OF SCIENCE AND MEDICINE IN SPORT
Volume 26, Issue 1, Pages 8-13

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.jsams.2022.10.015

Keywords

COVID-19; SARS-CoV-2; Athletes; Cardiovascular evaluation; Cardiopulmonary exercise test (CPET); Return-to-play (RTP)

Categories

Ask authors/readers for more resources

This study evaluated the cardiac involvement in competitive athletes after COVID-19 and found a low prevalence of myocarditis but a notable occurrence of uncommon premature ventricular contractions (PVCs). Some athletes were temporarily restricted from sports participation.
Objective: to evaluate the prevalence of cardiac involvement after COVID-19 in competitive athletes at return-to-play (RTP) evaluation, following the recommended Italian protocol including cardiopulmonary exercise test (CPET) and 24-Hour Holter monitoring.Design and methods: this is a single centre observational, cross-sectional study. Since October 2020, all competi-tive athletes (age >= 14 years) evaluated in our Institute after COVID-19, prior RTP were enrolled. The protocol dic-tated by the Italian governing bodies included: 12-lead ECG, blood test, CPET, 24-h ECG monitoring, spirometry. Cardiovascular Magnetic Resonance (CMR) was performed based on clinical indication.Results: 219 consecutive athletes were examined (59% male), age 23 years (IQR 19-27), 21% asymptomatic, 77% mildly symptomatic, 2% with previous pneumonia. The evaluation was performed after a median of 10 (6-17) days from negative SARS-CoV-2 swab. All athletes showed a good exercise capacity at CPET without cardiovascular and respiratory limitations. Uncom-mon premature ventricular contractions (PVCs) were found in 9.5% (n = 21) at CPET/Holter ECG monitoring. Two athletes (0.9%) were diagnosed with acute myocarditis (by CMR) and another one with new pericardial ef-fusion. All the three athletes were temporally restricted from sport participation.Conclusions: Myocarditis in competitive athletes screened after COVID-19 resolution was detected in a low mi-nority of the cases (0.9%). However, a non-negligible prevalence of uncommon PVCs (9%) was observed, either at CPET and/or Holter ECG monitoring, including all athletes with COVID-19 related cardiovascular abnormalities.(c) 2022 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available